Abstract:By using the prominent merit of poly( N -isopropylacrylamide) (PNIPAm) that can reversibly switch from a linear state to a coiled state with the change in temperature, in this work, gelatin was grafted with carboxylic end-capped PNIPAm as the matrix material to fabricate a physical entanglement crosslinked hydrogel microneedles (MNs) patch that can control drug release after application on the skin. The crystallization of the drug during the fabrication process of MNs was decreased due to the thermo-reversible sol-gel transition of the matrix materials. In addition, to increase the mechanical strength of the MNs and to decrease the application time, the gelatin-g-PNIPAm (GP) MNs patch was mounted onto solid MNs to fabricate a rapidly separating MNs system (RS-GP-MNs). The combination of the rapidly separating technique and the thermosensitive hydrogel provides the combined ability to efficiently deliver drug-loaded MNs into the skin within few seconds and to control drug release within the skin. Through a series of tests, we found that RS-GP-MNs showed suitable lower critical solution temperature and adequate crosslinking speed for practical application. The hypoglycemic effect in diabetic mice was characteristically controlled by insulin release through RS-GP-MNs as compared to the MNs made from unmodified gelatin. The proposed RS-GP-MNs system is potentially applicable to various hydrophilic small molecular and peptide medicines that require frequent dosing, thus providing an effective, noninvasive, and painless administration method with minimal safety concerns. Statement of Significance 1. Hydrogel microneedles that can be reversibly triggered and controllably release drugs at body temperature were fabricated. 2. Hydrogel microneedles prepared from gelatin-g-PNIPAm can avoid the use of a molecular crosslinker that is toxic and difficult to be completely removed. 3. Gelatin-g-PNIPAm with thermosensitive property showed appropriate molecular interactions with the drug and slowed down the crystallization speed of the drug in the solution.

Glucose-responsive soluble microneedle prepared with “Gelatin - hydroxyethylcellulose ethoxylate complex coacervate” for the transdermal drug delivery

Glucose-responsive hydrogel-based microneedles containing phenylborate ester bonds and N-isopropylacrylamide moieties and their transdermal drug delivery properties

Development of glucose/pH responsive smart hydrogel of carbopol and application in microneedles

Thermosensitive hydrogel microneedles for controlled transdermal drug delivery

Glucose‐Responsive Microneedle Patch With Variable Crosslinking Density and Flexible Core–Shell Structure for Insulin Delivery

Glucose-responsive insulin microneedle patches for long-acting delivery and release visualization

Glucose-Responsive Silk Fibroin Microneedles for Transdermal Delivery of Insulin

Microneedle-array patch with pH-sensitive formulation for glucose-responsive insulin delivery

Cross-Linking-Density-Changeable Microneedle Patch Prepared from a Glucose-Responsive Hydrogel for Insulin Delivery

"Smart" Matrix Microneedle Patch Made of Self‐Crosslinkable and Multifunctional Polymers for Delivering Insulin On‐Demand

Glucose-Responsive Microneedle Patches for Diabetes Treatment

Electrostatic-Interaction-Aided Microneedle Patch for Enhanced Glucose-Responsive Insulin Delivery and Three-Meal-Per-Day Blood-Glucose Regulation.

A Porous Reservoir-Backed Boronate Gel Microneedle for Efficient Skin Penetration and Sustained Glucose-Responsive Insulin Delivery

Bioresponsive Microneedles with a Sheath Structure for H2 O2 and Ph Cascade-Triggered Insulin Delivery.

Glucose-Responsive Microneedle Patch with High Insulin Loading Capacity for Prolonged Glycemic Control in Mice and Minipigs

Biodegradable Gelatin Methacryloyl Microneedles for Transdermal Drug Delivery

Microneedle Patches Loaded with Nanovesicles for Glucose Transporter-Mediated Insulin Delivery.

Colloidal crystal microneedle patch for glucose monitoring

Microneedle Patch Prepared from a Hydrogel by a Mild Method for Insulin Delivery

Preparation of phenylboronic acid‐based hydrogel microneedle patches for glucose‐dependent insulin delivery

Hydrogel Microneedles with Programmed Mesophase Transitions for Controlled Drug Delivery